Pharmacy Residency at MedStar Georgetown

Evaluation of ketamine for adjunctive pain management in sickle cell crisis: A single center, intra-comparison study
Naidelyn Medina, PharmD; Minhee Kang, PharmD, BCPS, BCOP; Lama Kanawati, PharmD, BCPS

Provider adherence to monitoring recommendations for oral anticancer medications at outpatient oncology clinics within a large academic medical system
Anas Hanini, PharmD; Pauline Guthrie, PharmD, Joshua Bailey, PharmD

Identification of oncology providers interest, use-cases, and barriers to use of pharmacogenomic testing
Meghna Bhatt, PharmD; Max Smith, PharmD, BCPS

Evaluation of the safety and efficacy of warfarin compared to DOACs following bioprosthetic valve replacement
Caitlin Benkart, PharmD; Victoria Ly, PharmD, BCCP; Wafaa Abou-Zeineddine, PharmD, BCPS

Evaluation of Angiotensin-Converting Enzyme Inhibitors and/or Beta-Blockers in Primary Prevention of Cardiac Dysfunction Caused by Anthracyclines and Trastuzumab in African American Breast Cancer Patients
Serena Mitaly, PharmD; Victoria Ly, PharmD, BCCP; Quan Li, PharmD, BCOP, BCPS, DPLA

Marijuana and Dietary Supplement Use in African American Hematology/Oncology Patients
Humam Alkhaled, PharmD; Quan Li, PharmD, BCOP, BCPS, DPLA

Effects of Immunosuppression Titration by Single Point Immune Cell Function Assay in Heart Transplants
Rita Chen, PharmD; Bolanle Lawuyi, PharmD, BCCP

Evaluation of the Safety of the New Alcohol Containing Cyclophosphamide Formulation
Tonya Wright, PharmD; Quan Li, PharmD, BCOP, BCPS, DPLA

Evaluation of patients switching from direct oral anti-Xa inhibitors to parental anticoagulation in tertiary care hospital
Betlihem Semma, PharmD; Lisa Peters, PharmD, BCPS

Impact of pharmacist driven patient education on acute coronary syndrome patient outcomes
Rohina Bayat, PharmD; Lisa Peters, PharmD, BCPS

Impact of ketamine use on pain management in the emergency department
Manraj Kalkat, PharmD; Lama Kanawati, PharmD, BCPS

Pharmacist managed anticoagulation in LVAD patients in a large tertiary care hospital
Jessica Szatkowski, PharmD; Victoria Ly, PharmD

Evaluation of moderate sedation outcomes in procedural areas by non-anesthesiologists
Nancy Tang, PharmD; Cynthia Willis, PharmD

Appropriateness of empiric antimicrobial treatment of septic patients transferred from skilled nursing facilities to a tertiary hospital
Dilbi Hussein, PharmD; Lama Kanawati, PharmD, BCPS

Evaluation of fentanyl transdermal systems for pain management in a tertiary hospital
Carlette Cavenaugh, PharmD; Diana Stewart, PharmD, BCPS

Evaluating the impact of nasal screening for methicillin-resistant Staphylococcus aureus (MRSA) on vancomycin therapy in the intensive care unit
Roshani Patel, PharmD; Jennifer Brandt, PharmD, FASHP, BCCCP

Impact of a multiplex polymerase chain reaction system on antibiotic optimization Assessing the incidence of medication-related patient safety events
Gayle Unhjem, PharmD, MHS; Jennifer Brandt, PharmD, FASHP, BCCCP

Trace Element Supplementation in Burn Patients
Annmarie Cristiano, PharmD; Jennifer Brandt, PharmD, FASHP, BCCCP

Evaluation of ketamine use for postoperative pain management
Inna Perinskaya, PharmD; Lama Kanawati, PharmD, BCPS

Assessing the incidence of medication-related patient safety event reports
Lisa Pickmans, PharmD; Jennifer Brandt, PharmD, FASHP, BCCCP

Implementation of operating room pharmacy services in a tertiary care hospital
Inna Perinskaya, PharmD; Cynthia Willis, PharmD

Evaluation of vancomycin-associated nephrotoxicity before and after implementation of an intensive pharmacist monitoring program
Sarah El-Gendi, PharmD; Zetta Leftridge, PharmD

Medication Safety events secondary to pump programming errors before and after implementation of an infusion management system
Taylor Kravatz, PharmD; Cynthia Willis, PharmD

Appropriateness of surgical antibiotic prophylaxis before and after guideline implementation
Erin Grannan, PharmD; Jennifer Brandt, PharmD, FASHP

De-escalation of broad-spectrum antibiotics in the intensive care unit
Mary McIntyre, PharmD; Jennifer Brandt, PharmD, FASHP

During the first month of the program (July), residents go through orientation to MedStar Georgetown University Hospital and Department of Pharmacy Services.

Residents learn about the institution, its mission and philosophy, as well as become familiar with the scope of our pharmacy services—distribution process, satellite pharmacy services (critical care, pediatric, oncology and research), and in the operating room.

The following eleven months will be comprised of clinical and practice management related rotations. The schedule will be developed by the resident and the residency program administrative director during the orientation period but can always be subject to change.

There are seven required learning experiences with three longitudinal aspects: staffing & drug distribution, management of medical emergency (code response), and antiretroviral inpatient monitoring. There are several elective rotations allow for a diverse or specialized residency experience.